Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.

Saved in:
Bibliographic Details
Title: Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.
Authors: Hagedoorn NN; Centre for International Health, University of Otago, Dunedin, New Zealand; ETZ, Tilburg, the Netherlands., Murthy S; Centre for International Health, University of Otago, Dunedin, New Zealand., Marchello CS; Centre for International Health, University of Otago, Dunedin, New Zealand., Williman J; Department of Population Health, University of Otago, Christchurch, New Zealand., Ahmmed F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, USA., Basnyat B; Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Lalitpur, Nepal., Carter AS; Sabin Vaccine Institute, Washington, DC, USA., Datta S; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA., Dehraj IF; Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan., Doyle K; Sabin Vaccine Institute, Washington, DC, USA., Garrett DO; Sabin Vaccine Institute, Washington, DC, USA., Jacob J; Department of Clinical Microbiology, Christian Medical College, Vellore, India., Jeon H; International Vaccine Institute, Seoul, Republic of Korea; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, UK., John J; Department of Community Health, Christian Medical College Vellore, Vellore, India., Khanam F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Lee J; International Vaccine Institute, Seoul, Republic of Korea; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Marks F; International Vaccine Institute, Seoul, Republic of Korea; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, UK; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany; The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region., Naga SR; Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA., Newton PN; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos., Patel PD; Malawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi; University of Liverpool, Liverpool, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Qadri F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Qamar FN; Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan., Roberts T; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Seidman JC; Sabin Vaccine Institute, Washington, DC, USA., Shakya M; Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Lalitpur, Nepal., Shrestha S; Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Lalitpur, Nepal., Tadesse BT; International Vaccine Institute, Seoul, Republic of Korea; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Tamrakar D; Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal., Vongsouvath M; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Yousafzai MT; Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan., Crump JA; Centre for International Health, University of Otago, Dunedin, New Zealand. Electronic address: john.crump@otago.ac.nz.
Source: Vaccine [Vaccine] 2026 Jul 11; Vol. 85, pp. 128691. Date of Electronic Publication: 2026 May 18.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2026.128691